The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain

被引:86
作者
Brehm, A [1 ]
Ohbo, K [1 ]
Scholer, H [1 ]
机构
[1] EUROPEAN MOL BIOL LAB,GENE EXPRESS PROGRAMME,D-69117 HEIDELBERG,GERMANY
关键词
D O I
10.1128/MCB.17.1.154
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The POU transcription factor Oct-4 is expressed in totipotent and pluripotent cells of the early mouse embryo and the germ cell lineage, Transactivation capacities of regions flanking the DNA binding domain of Oct-4 were analyzed in undifferentiated and differentiated cell lines, The amino- and carboxy-terminal regions (N domain and C domain) fused to the Gall DNA binding domain both functioned as transactivation domains in all cell lines tested. However, the C domain failed to activate transcription in some cell lines in the context of the native protein. The underlying regulator, mechanism appears to involve the POU domain of Oct-4 and can discriminate between different POU domains, since constructs in,which the C domain was instead fused to the POU domain of Pit-1 were again equally active in all cell lines, These results indicate that the C domain is subject to cell-type-specific regulation mediated by the Oct-4 POU domain. Phosphopeptide analysis revealed that the cell-type-specific difference of C-domain activity correlates with a difference in Oct-4 phosphorylation status, Since Oct-4 is expressed in a variety of distinct cell types during murine embryogenesis, these results suggest an additional regulatory mechanism for determining Oct-4 function in rapidly changing cell types during development.
引用
收藏
页码:154 / 162
页数:9
相关论文
共 58 条
[1]   FUNCTIONAL DIFFERENCES BETWEEN THE OCT2 TRANSACTIVATION DOMAINS DETERMINE THE TRANSACTIVATION POTENTIAL OF INDIVIDUAL OCT2 ISOFORMS [J].
ANNWEILER, A ;
ZWILLING, S ;
WIRTH, T .
NUCLEIC ACIDS RESEARCH, 1994, 22 (20) :4250-4258
[2]   OCT2 TRANSACTIVATION FROM A REMOTE ENHANCER POSITION REQUIRES A B-CELL-RESTRICTED ACTIVITY [J].
ANNWEILER, A ;
MULLERIMMERGLUCK, M ;
WIRTH, T .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (07) :3107-3116
[3]  
[Anonymous], 1988, Antibodies: A Laboratory Manual
[4]   V-SRC AND EJ RAS ALLEVIATE REPRESSION OF C-JUN BY A CELL-SPECIFIC INHIBITOR [J].
BAICHWAL, VR ;
PARK, A ;
TJIAN, R .
NATURE, 1991, 352 (6331) :165-168
[5]   THE CELL-TYPE-SPECIFIC ACTIVATOR REGION OF C-JUN JUXTAPOSES CONSTITUTIVE AND NEGATIVELY REGULATED DOMAINS [J].
BAICHWAL, VR ;
PARK, A ;
TJIAN, R .
GENES & DEVELOPMENT, 1992, 6 (08) :1493-1502
[6]   CONTROL OF C-JUN ACTIVITY BY INTERACTION OF A CELL-SPECIFIC INHIBITOR WITH REGULATORY DOMAIN-DELTA - DIFFERENCES BETWEEN V-JUN AND C-JUN [J].
BAICHWAL, VR ;
TJIAN, R .
CELL, 1990, 63 (04) :815-825
[7]   THE PITUITARY-SPECIFIC TRANSCRIPTION FACTOR-GHF-1 IS A HOMEOBOX-CONTAINING PROTEIN [J].
BODNER, M ;
CASTRILLO, JL ;
THEILL, LE ;
DEERINCK, T ;
ELLISMAN, M ;
KARIN, M .
CELL, 1988, 55 (03) :505-518
[8]   DIFFERENTIAL POSITIVE CONTROL BY OCT-1 AND OCT-2 - ACTIVATION OF A TRANSCRIPTIONALLY SILENT MOTIF THROUGH OCT-1 AND VP16 CORECRUITMENT [J].
CLEARY, MA ;
STERN, S ;
TANAKA, M ;
HERR, W .
GENES & DEVELOPMENT, 1993, 7 (01) :72-83
[9]  
COLLARINI EJ, 1992, DEVELOPMENT, V116, P193
[10]   TRANSCRIPTIONAL ACTIVATION AND REPRESSION, 2 PROPERTIES OF THE LYMPHOID-SPECIFIC TRANSCRIPTION FACTOR OCT-2A [J].
FRIEDL, EM ;
MATTHIAS, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 234 (01) :308-316